Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

NCRI 2012 /
Advances in the treatment of prostate cancer

4th - 7th Nov 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.11.12
Views: 2068
Rating:

Prof Malcolm Mason – Cardiff University, UK

Prof Malcolm Mason speaks to ecancer.tv about the developments that have been made in the understanding and treatment of prostate cancer, explains the importance of androgen in prostate cancer and considers the possibility of a future cure for prostate cancer.

 

Prof Mason concludes by discusses other new treatment techniques such as radio-surgery and robotic surgery and talks about the questions that remain over the use of PSA screening. 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation